TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · major macro event coming up
ACRV

Acrivon Therapeutics, Inc.

Healthcare · Biotechnology

2.10$ +1.0% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

Acrivon Therapeutics, Inc. (ACRV) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 99 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ACRV
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
151 138 121 231 215 197 176 159 145 130 108 99
144 130 112 182 189 182 151 138 130 120 99 91
30 36 25 46 43 40 39 42 35 41 34 41
142 127 110 181 187 179 150 137 129 119 98 90
13 17 13 15 18 20 16 16 17 17 12 12
9.3 13 9.0 11 15 17 14 13 15 16 11 11
0.8 0.9 0.9 1.0 1.0 1.1 1.1 1.1 1.2 1.2 1.2 1.1
1.5 5.0 2.1 1.3 1.5 0.8 3.7 1.2 1.0 2.3 1.2 0.9
138 121 108 216 197 177 160 143 129 113 96 87
-97 -116 -133 -152 -174 -197 -217 -238 -256 -275 -294 -312
22 22 23 36 38 38 38 38 39 39 39 42

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?